Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling by Bin Zhang, Bin Zhang, Bin Zhang, Bin Zhang, Jingyi Zhang, Jingyi Zhang, Jingyi Zhang, Jingyi Zhang, Chenyang Zhang, Chenyang Zhang, Chenyang Zhang, Chenyang Zhang, Xuelian Zhang, Xuelian Zhang, Xuelian Zhang, Xuelian Zhang, Jingxue Ye, Shihuan Kuang, Guibo Sun, Guibo Sun, Guibo Sun, Guibo Sun, Xiaobo Sun, Xiaobo Sun, Xiaobo Sun, Xiaobo Sun

Subjects: Get full text

Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation by Mohamed F. AbdelGhany, Waleed GamalEldin Khaleel, Asmaa Omar Ahmed, Ahmad BaheyElden Ahmed, Lamees M. Bakkar

Subjects: Get full text

The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study by Guoqing Hou, Qian Liao, Huihui Ma, Yan Shu, Shengzhi Zeng, Yongmei Zhou, Liangjun Luo, Gang Zhao, Tao He, Mingjiang Liu, Jianhong Tao, Wei Hua, Xiaoping Li

Subjects: “…cardiomyopathy…”
Get full text

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy by Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, Katarina Johansson, Mark H. Rozenbaum, Anne Mette Strand, Merja Vakevainen, Johanna Kuusisto, Einar Gude, J. Gustav Smith, Finn Gustafsson

Subjects: Get full text

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy by Sarala Raj Murthi, Andreas Petry, Bachuki Shashikadze, Jan B. Stöckl, Manuel Schmid, Gianluca Santamaria, Karin Klingel, Damir Kračun, Xinpei Chen, Sabine Bauer, Joachim P. Schmitt, Florian Flenkenthaler, Josh Gorham, Christopher N. Toepfer, David Potěšil, Pavel Hruška, Zbyněk Zdráhal, Zsuzsanna Mayer, Mathieu Klop, Luisa Lehmann, Yishi Qin, Laura Papanakli, Nadine Spielmann, Alessandra Moretti, Thomas Fröhlich, Peter Ewert, Stefan Holdenrieder, Jonathan G. Seidman, Christine E. Seidman, Agnes Görlach, Cordula M. Wolf

Subjects: “…Hypertrophic cardiomyopathy…”
Get full text

TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes by Wenrui Sun, Jianchao Zhang, Shuang Li, Wanrong Fu, Yangyang Liu, Mengduan Liu, Jianzeng Dong, Xiaoyan Zhao, Xiaowei Li

Subjects: Get full text

A New, Easy-to-Learn, Fear-Free Method to Stop Purring During Cardiac Auscultation in Cats by Tessa Vliegenthart, Viktor Szatmári

Subjects: Get full text

A murine model of acute and prolonged abdominal sepsis, supported by intensive care, reveals time-dependent metabolic alterations in the heart by Bart Jacobs, Inge Derese, Sarah Derde, Sarah Vander Perre, Lies Pauwels, Greet Van den Berghe, Jan Gunst, Lies Langouche

Subjects: Get full text

Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction by Natsuko Inagaki, Yasuyoshi Takei, Tsuguhisa Hatano, Yasuyuki Takada, Yoshinao Yazaki, Hisanori Kosuge, Masatake Kobayashi, Shinji Suzuki, Tomohiro Umezu, Masahiko Kuroda, Kazuhiro Satomi, Takeharu Hayashi

Subjects: Get full text

Takotsubu Cardiomyopathy Patient With Coronary Artery Disease: The Chicken or the Egg by Chara Ude, Ayman Helal, Ibrahim Antoun

Subjects: Get full text

The role of NF-κB in diabetic cardiomyopathy by Huang-Jun Liu, Le-Kun Gui, Han Wei, Xing-Yu Zhou, Zhen-Lan Liu, Li-Jun Jin

Subjects: “…diabetic cardiomyopathy…”
Get full text

Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy by Meixin Shi, Bingbing Zhao, Wenjie Cai, Hui Yuan, Xiao Liang, Zhitao Li, Xinyu Liu, Ye Jin, Xi Liu, Can Wei

Subjects: “…diabetic cardiomyopathy…”
Get full text

Primary Terminal Haemochromatosis in a 50 Year-Old Patient by M. I. Gonik, M. S. Zharkova, O. Yu. Kiseleva, E. V. Berezina, Sh. A. Ondos, Yu. V. Lerner, E. A. Kogan, V. T. Ivashkin

Subjects: Get full text

Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy by Martin Lindgren, Josefina Robertson, Martin Adiels, Maria Schaufelberger, Maria Åberg, Kjell Torén, Margda Waern, N. David Åberg, Annika Rosengren

Subjects: Get full text

Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy by Levent PAY, Ahmet Cagdas YUMURTAS, Seyda DERELI, Tugba CETIN, Hikmet KADI, Tufan CINAR, Mert Ilker HAYIROGLU

Subjects: “…hypertrophic cardiomyopathy…”
Get full text

Global burden and attributable risk factors of inflammatory cardiomyopathy and myocarditis from 1990 to 2019 by Guilan Wu, Wenlin Xu, Shuyi Wu, Chengfu Guan, Jinhua Zhang

Subjects: “…Inflammatory cardiomyopathy…”
Get full text

Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysisResearch in context by Anis Rassi, Jr, Alyssa Grimshaw, Ashwin Sarwal, Ranjit Sah, Sangam Shah, Nelson I. Agudelo Higuita, Fabio Mahamed Rassi, Michaele Francesco Corbisiero, Hannah M. Kyllo, Jordan Stellern, Samantha Kaplan, Luis A. Marcos, Edgar A. Ramírez-García, Martin Casapia, Peter Hotez, Maria Elena Bottazzi, Shital Patel, Carlos Franco-Paredes, José Antonio Marin-Neto, Andrés F. Henao-Martínez

Subjects: Get full text

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy by B.M. Todurov, G.I. Kovtun, A.V. Khokhlov, O.V. Pantazi, A.O. Shpachuk, A.Yu. Melnik, A.O. Maksakov, A.S. Batsiun

Subjects: Get full text

Gut microbiota and atrial cardiomyopathy by Tingting Sun, Beibei Song, Bo Li

Subjects: “…atrial cardiomyopathy…”
Get full text

Contemporary Management of Patients With Chagas Cardiomyopathy in Bolivia by Evan Czulada, BS, Sascha Bercovitch, BA, Yazan Alshawkani, MD, Natalia Noya Weise, MD, Adriana E. Hernani Rodrigo, BS, Ronald Gustavo Durán Saucedo, MD, Marcelo Buhezo Chamón, MD, Robert H. Gilman, MD, David T. Martin, MD

Subjects: “…Chagas cardiomyopathy…”
Get full text